| scholarly article | Q13442814 |
| P50 | author | Thomas Guillard | Q56805690 |
| P2093 | author name string | E Cambau | |
| C de Champs | |||
| F Chau | |||
| B Fantin | |||
| L Massias | |||
| P2860 | cites work | Plasmid-mediated quinolone resistance: a multifaceted threat | Q24645356 |
| Emergence and dissemination of quinolone-resistant Escherichia coli in the community | Q33978075 | ||
| Mechanisms of action and resistance of older and newer fluoroquinolones | Q34030757 | ||
| Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models | Q34030770 | ||
| Ciprofloxacin dosage and emergence of resistance in human commensal bacteria | Q34104262 | ||
| Urinary tract infections: disease panorama and challenges | Q34136716 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro | Q35130328 | ||
| Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli | Q35879095 | ||
| Quinolone-mediated bacterial death. | Q36921143 | ||
| High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals | Q37072029 | ||
| Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection | Q37392904 | ||
| Antibiotic consumption and link to resistance | Q37444150 | ||
| Extravascular penetration of ciprofloxacin. A review | Q37941048 | ||
| Acalculous nontyphoidal salmonellal cholecystitis requiring surgical intervention despite ciprofloxacin therapy: report of three cases | Q39231348 | ||
| Conjugative plasmid conferring resistance to olaquindox | Q39740621 | ||
| High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China | Q41388247 | ||
| Rapid detection of aac(6')-Ib-cr quinolone resistance gene by pyrosequencing. | Q41865434 | ||
| Practical disk-based method for detection of Escherichia coli clinical isolates producing the fluoroquinolone-modifying enzyme AAC(6')-Ib-cr | Q42773186 | ||
| Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden | Q43131315 | ||
| Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant | Q43367661 | ||
| Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model | Q44121055 | ||
| Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin | Q44709393 | ||
| Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1. | Q46536125 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases | Q47653135 | ||
| Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. | Q50131892 | ||
| Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR. | Q50520330 | ||
| Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. | Q51188136 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model. | Q54334733 | ||
| Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis. | Q54485886 | ||
| Urinary tract infection in adults: research priorities and strategies | Q57991131 | ||
| The intestinal elimination of ciprofloxacin in the rat | Q72695838 | ||
| EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution | Q73418024 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| pyelonephritis | Q506652 | ||
| murine model | Q122890741 | ||
| P304 | page(s) | 5830-5835 | |
| P577 | publication date | 2013-09-09 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro | |
| P478 | volume | 57 |
| Q37588992 | Bacterial plasmid-mediated quinolone resistance genes in aquatic environments in China |
| Q36076086 | Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection. |
| Q41446800 | Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study. |
| Q42002757 | Discrimination between native and Tn6010-associated oqxAB in Klebsiella spp., Raoultella spp., and other Enterobacteriaceae by using a two-step strategy |
| Q64955622 | Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase. |
| Q36196200 | Fluoroquinolone Resistance Mechanisms and population structure of Enterobacter cloacae non-susceptible to Ertapenem in North-Eastern France. |
| Q36106267 | Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure. |
| Q40587123 | Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli. |
| Q92091298 | In Vitro Synergy and In Vivo Activity of Tigecycline-Ciprofloxacin Combination Therapy against Vibrio vulnificus Sepsis |
| Q37701591 | Mechanism of quinolone action and resistance |
| Q92393023 | Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications |
| Q90636536 | Palmatine Is a Plasmid-Mediated Quinolone Resistance (PMQR) Inhibitor That Restores the Activity of Ciprofloxacin Against QnrS and AAC(6')-Ib-cr-Producing Escherichia coli |
| Q92865986 | Phenotypic screening for quinolone resistance in Escherichia coli |
| Q30240591 | Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. |
| Q26752640 | The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity |
Search more.